-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Background: Nearly a year after the World Health Organization announced the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) pandemic, increasing data has improved our approach to it
Nearly a year after the World Health Organization announced the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) pandemic, ever-increasing data has improved our approach to it
Results: Most patients (68.
Table 1 Laboratory and radiological examination results of inpatients
Table 1 Laboratory and radiological examination results of inpatients
Table 2 Summary of COVID-19-related results of a study that recruited more than 100 AARD patients
Table 2 Summary of COVID-19-related results of a study that recruited more than 100 AARD patients
Although most patients with AARD have a mild disease course, certain underlying disease characteristics and COVID-19-related manifestations should remind doctors to be vigilant.
Bakasis AD, Mavragani CP, Boki KA,et al.
COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review.
Leave a message here
